202 related articles for article (PubMed ID: 38130152)
1. Commentary: Nanoparticle-Based Chemotherapy Delivery and Potential Health Risks: Prospects for Effective Clinical Translation.
Assefa D; Melaku T; Alemu S
Technol Cancer Res Treat; 2023; 22():15330338231220171. PubMed ID: 38130152
[TBL] [Abstract][Full Text] [Related]
2. Reappraisal of anticancer nanomedicine design criteria in three types of preclinical cancer models for better clinical translation.
Luan X; Yuan H; Song Y; Hu H; Wen B; He M; Zhang H; Li Y; Li F; Shu P; Burnett JP; Truchan N; Palmisano M; Pai MP; Zhou S; Gao W; Sun D
Biomaterials; 2021 Aug; 275():120910. PubMed ID: 34144373
[TBL] [Abstract][Full Text] [Related]
3. Drug delivery and nanoparticles:applications and hazards.
De Jong WH; Borm PJ
Int J Nanomedicine; 2008; 3(2):133-49. PubMed ID: 18686775
[TBL] [Abstract][Full Text] [Related]
4. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticle-Induced Complement Activation: Implications for Cancer Nanomedicine.
La-Beck NM; Islam MR; Markiewski MM
Front Immunol; 2020; 11():603039. PubMed ID: 33488603
[TBL] [Abstract][Full Text] [Related]
6. Nanoparticle-assisted combination therapies for effective cancer treatment.
Hu CM; Aryal S; Zhang L
Ther Deliv; 2010 Aug; 1(2):323-34. PubMed ID: 22816135
[TBL] [Abstract][Full Text] [Related]
7. Integrating Therapeutic Ultrasound With Nanosized Drug Delivery Systems in the Battle Against Cancer.
Moradi Kashkooli ; Jakhmola A; Ferrier GA; Hornsby TK; Tavakkoli JJ; Kolios MC
Technol Cancer Res Treat; 2023; 22():15330338231211472. PubMed ID: 37946517
[TBL] [Abstract][Full Text] [Related]
8. Radiation effects on the tumor microenvironment: Implications for nanomedicine delivery.
Stapleton S; Jaffray D; Milosevic M
Adv Drug Deliv Rev; 2017 Jan; 109():119-130. PubMed ID: 27262923
[TBL] [Abstract][Full Text] [Related]
9. Nanoscale drug delivery for targeted chemotherapy.
Xin Y; Huang Q; Tang JQ; Hou XY; Zhang P; Zhang LZ; Jiang G
Cancer Lett; 2016 Aug; 379(1):24-31. PubMed ID: 27235607
[TBL] [Abstract][Full Text] [Related]
10. Overcoming obstacles in the tumor microenvironment: Recent advancements in nanoparticle delivery for cancer theranostics.
Overchuk M; Zheng G
Biomaterials; 2018 Feb; 156():217-237. PubMed ID: 29207323
[TBL] [Abstract][Full Text] [Related]
11. Tumor microenvironment and nanotherapeutics: intruding the tumor fort.
Ravi Kiran AVVV; Kusuma Kumari G; Krishnamurthy PT; Khaydarov RR
Biomater Sci; 2021 Nov; 9(23):7667-7704. PubMed ID: 34673853
[TBL] [Abstract][Full Text] [Related]
12. Critical quality attributes in the development of therapeutic nanomedicines toward clinical translation.
Taha MS; Padmakumar S; Singh A; Amiji MM
Drug Deliv Transl Res; 2020 Jun; 10(3):766-790. PubMed ID: 32170656
[TBL] [Abstract][Full Text] [Related]
13. Organoids technology for advancing the clinical translation of cancer nanomedicine.
Zhao DK; Liang J; Huang XY; Shen S; Wang J
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(5):e1892. PubMed ID: 37088100
[TBL] [Abstract][Full Text] [Related]
14. Tumor heterogeneity and nanoparticle-mediated tumor targeting: the importance of delivery system personalization.
Swetha KL; Roy A
Drug Deliv Transl Res; 2018 Oct; 8(5):1508-1526. PubMed ID: 30128797
[TBL] [Abstract][Full Text] [Related]
15. Combined cancer therapeutics-Tackling the complexity of the tumor microenvironment.
Roma-Rodrigues C; Raposo LR; Valente R; Fernandes AR; Baptista PV
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Sep; 13(5):e1704. PubMed ID: 33565269
[TBL] [Abstract][Full Text] [Related]
16. Challenges and pitfalls in the development of liposomal delivery systems for cancer therapy.
Moosavian SA; Bianconi V; Pirro M; Sahebkar A
Semin Cancer Biol; 2021 Feb; 69():337-348. PubMed ID: 31585213
[TBL] [Abstract][Full Text] [Related]
17. Spatial heterogeneity of nanomedicine investigated by multiscale imaging of the drug, the nanoparticle and the tumour environment.
de Maar JS; Sofias AM; Porta Siegel T; Vreeken RJ; Moonen C; Bos C; Deckers R
Theranostics; 2020; 10(4):1884-1909. PubMed ID: 32042343
[TBL] [Abstract][Full Text] [Related]
18. Chloroquine and nanoparticle drug delivery: A promising combination.
Pelt J; Busatto S; Ferrari M; Thompson EA; Mody K; Wolfram J
Pharmacol Ther; 2018 Nov; 191():43-49. PubMed ID: 29932886
[TBL] [Abstract][Full Text] [Related]
19. In situ cellular hitchhiking of nanoparticles for drug delivery.
Udofa E; Zhao Z
Adv Drug Deliv Rev; 2024 Jan; 204():115143. PubMed ID: 38008185
[TBL] [Abstract][Full Text] [Related]
20. Responsive Role of Nanomedicine in the Tumor Microenvironment and Cancer Drug Resistance.
Sa P; Sahoo SK; Dilnawaz F
Curr Med Chem; 2023; 30(29):3335-3355. PubMed ID: 36154585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]